SCHEMBL29358993

SCHEMBL29358993

CC(C)CCCC(C)C1CCC2C3CCC(C(C)CO)C(C)(CCO)C3CCC12C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 2/20 0.61
▸ FNTB P49356 2/20 0.61
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ INPP5D Q92835 1/20 0.56
▸ SRD5A1 P18405 4/20 0.53
▸ SRD5A2 P31213 3/20 0.53
▸ NPC1L1 Q9UHC9 3/20 0.53
▸ CDC25A P30304 5/20 0.52
▸ POLA1 P09884 1/20 0.52
▸ CDC25B P30305 3/20 0.51
▸ USP2 O75604 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ ABCB1 P08183 1/20 0.49
▸ OSBP P22059 1/20 0.49
▸ RORC P51449 1/20 0.49
▸ OSBP2 Q969R2 1/20 0.49
▸ CYP46A1 Q9Y6A2 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13153840 0.87 FNTA (0.59) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL4940767 0.84 FNTA (0.61) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL24104660 0.83 FNTA (0.66) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL17817290 0.83 FNTA (0.66) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL17817647 0.83 FNTA (0.59) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL23451210 0.80 FNTA (0.61) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL14722419 0.78 FNTA (0.80) FNTAFNTBCYP2D6CYP2C19SRD5A1
SCHEMBL17817291 0.78 FNTA (0.64) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL17817641 0.78 FNTA (0.56) FNTAFNTBCYP2D6CYP2C19INPP5D
SCHEMBL22919551 0.78 FNTA (0.58) FNTAFNTBCYP2D6CYP2C19INPP5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250193804-A1 Method for allocating MCS and Resource Block for Uplink Transmission in 5G NR System without closed-loop power control EUCAST CO., LTD. (KR) 2025-06-12 — — US claimed
CN-122056902-A Pharmaceutical application of harpagoside 金陵药业股份有限公司 2026-05-19 — — CN disclosed
CN-122011139-A Microbacterium MccY mutant resisting thermolysin and application thereof 华南农业大学 2026-05-12 — — CN disclosed
US-12616828-B2 Detecting heating of implanted coil hermetic package when misaligned BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-05-05 — — US disclosed
US-12576261-B2 Account for preload changes in the left ventricle BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-03-17 — — US disclosed
US-20260069216-A1 MULTIPLE PARTIALLY REDUNDANT BIOMETRIC SENSING DEVICES POLTORAK TECH LLC (US) 2026-03-12 — — US disclosed
US-20250363353-A1 ARTIFICIAL INTELLIGENCE DEVICE FOR SKIPPY SIMULTANEOUS SELF-SPECULATIVE DECODING AND METHOD THEREOF LG ELECTRONICS INC. (KR) 2025-11-27 — — US disclosed
US-12465292-B2 Multiple partially redundant biometric sensing devices POLTORAK TECHNOLOGIES LLC (US) 2025-11-11 — — US disclosed
US-20250293795-A1 DATA PROCESSING METHOD AND APPARATUS HUAWEI TECHNOLOGIES CO., LTD. (CN) 2025-09-18 — — US disclosed
EP-4614912-A1 DATA PROCESSING METHOD AND APPARATUS Huawei Technologies Co., Ltd. (CN) 2025-09-10 — — EP disclosed
CN-111062432-B Semantically multi-modal image generation method 华中科技大学 2022-03-25 — — CN disclosed
US-11273299-B2 Heart rate measurement using blood pump impeller location HEARTWARE, INC. (US) 2022-03-15 — — US disclosed
WO-2022051063-A1 METHOD FOR PUMP START IN A FULLY IMPLANTED LVAD SYSTEM WHEN MULTIPLE POWER SOURCES MAY BE PRESENT MEDTRONIC, INC. (US) 2022-03-10 — — WO disclosed
US-20220062516-A1 METHOD OF ESTIMATING POWER DISSIPATED IN FOREIGN OBJECT MEDTRONIC, INC. 2022-03-03 — — US disclosed
US-20220062514-A1 METHOD FOR PUMP START IN A FULLY IMPLANTED LVAD SYSTEM WHEN MULTIPLE POWER SOURCES MAY BE PRESENT BOSTON SCIENTIFIC SCIMED, INC. 2022-03-03 — — US disclosed
WO-2022026196-A1 POWER SOURCE SELECTION FOR A FULLY IMPLANTABLE LVAD SYSTEM MEDTRONIC, INC. (US) 2022-02-03 — — WO disclosed
US-20220032035-A1 EARLY WARNING OF LVAD THROMBUS FORMATION BOSTON SCIENTIFIC SCIMED, INC. 2022-02-03 — — US disclosed
US-20220031919-A1 POWER SOURCE SELECTION FOR A FULLY IMPLANTABLE LVAD SYSTEM BOSTON SCIENTIFIC SCIMED, INC. 2022-02-03 — — US disclosed
US-20220026391-A1 ESTIMATING COIL IMPLANT DEPTH FOR WIRELESS POWER TRANSFER MEDTRONIC, INC. 2022-01-27 — — US disclosed
WO-2022020066-A1 ESTIMATING COIL IMPLANT DEPTH FOR WIRELESS POWER TRANSFER MEDTRONIC, INC. (US) 2022-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576261-B2 Account for preload changes in the left ventricle TNNT2, TNNI3, TNNC1 FNTA 582/4885FNTB 777/4885CYP2D6 3431/4885
US-12616828-B2 Detecting heating of implanted coil hermetic package when misaligned TET1, HSF1, TET3 FNTA 2150/4885FNTB 2950/4885CYP2D6 3269/4885
US-20260069216-A1 MULTIPLE PARTIALLY REDUNDANT BIOMETRIC SENSING DEVICES VEGFA, KDR, TGFBR1 FNTA 4348/4885FNTB 4716/4885CYP2D6 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback